Global molecular biology enzymes reagents and kit market was valued at USD 12.7 million in 2019. It is projected to grow at a compound annual rate (CAGR of 11.0%) between 2020 and 2027. The life sciences research that are used to manage medical conditions have been greatly influenced by technological advances in molecular Biology. This has fueled the demand for molecular science consumables. The market for molecular biological enzymes, kits, and reagents is growing rapidly due to the availability of accurate computational tools, as well as continuous updating biological databases. Systems biology and Omics technology are two of the most prominent emerging concepts in molecular medicine. Researchers can use multi-omics-based technologies such as systems biology, computational power and Bioinformatics to help them better understand disease diversity, disease progression, drug resistance, and molecular heterogeneity in complex pathologies.
The demand for molecular enzymes and reagents is increasing due to omics-based research. Technology and scientific advances have played an important role in shaping product landscapes. This has led to the creation of new guidelines. Common federal agencies such as the Food and Drug Administration and the World Health Organization assess and manage the potential health and environmental risks associated with these products. These factors encourage the use of products under this market for molecular biological enzymes, kits, and reagents.
The emergence of single cell genome sequencing which offers a viable method for accurate assessment of biomolecules including RNA, DNA and chromatin has also accelerated revenue growth. This allows for a better understanding and appreciation of biological diversity by isolating these molecules from one cell. This increases the potential for single-cell sequencing and creates lucrative opportunities to operating companies to profit from the avenues.
The market for molecular biology enzymes, reagents, and kits is driven by constant improvement in the efficiency and specificity of restriction enzymes. These enzymes are crucial in physical mapping DNA across multiple applications, such as DNA fingerprinting or methylation analysis. Research has shown that this enzyme is widely used for the characterization of single cells and for epigenomic and genomic studies. This has subsequently fueled the growth in the market for molecular biological enzymes, reagents, and kits.
With a revenue share in 2019 of 68.5%, kits and reagents dominated molecular biology enzymes and other reagents. The wide range of kits and reagents available and the innovative product development by key companies are two reasons for this success. Asuragen, Inc., introduced the AmplideX PCR/CE SMN1/2 kit in March 2019. This is a reliable and fast method to detect SMN2 or SMN1 exon 7 copies within just 4 hours. It uses a Polymerase Chain Reaction, (PCR), and is intended for molecular diagnostic purposes.
Biotechnology and healthcare companies have been encouraged to produce more RT-PCR-based test kits due to the exponential increase in COVID-19 cases worldwide. According to Thermo Fisher, it plans to produce 5.0 million more COVID-19 tests. The increase in commercially available COVID-19 products is expected to boost the demand for kits, reagents and other COVID-19 diagnostic tools. As a result of the pandemic, Proteinases enzymes have been used in diagnosis.
Cloning technology is now a standard laboratory technology and manufacturers can provide many enzymes to generate and manipulate nucleic acid. The technology has evolved from cloning a single DNA fragment to the assembly multiple DNA fragments into one contiguous DNA stretch. The advancements in cloning technology will have a significant impact on the growth of molecular biology enzymes during the forecast period.
In 2019, the largest revenue share in the molecular biology enzymes reagents kits market was 34.9%. This segment is expected to expand at a rapid pace. The introduction of Next Generation Sequencing (NGS) has made great strides in genetic research and the discovery human diseases. NGS analysis of tumor epigenomics and genomics drives biomarker discoveries for cancer diagnosis and tumor stratification.
NGS offers many benefits, including the detection of the smallest mutation possible, faster combined detection of SNPs and larger abnormalities, as well as the best combination of high-throughput speed and resolution. The demand for sequencing will also increase due to personalized medicine and targeted and whole-exome sequencing. This segment also sees widespread adoption of these technologies, which accelerates the use of molecular biology products.
In 2019, PCR accounted for the second largest revenue share in the market of molecular biology enzymes and reagents. MiniPCR has made it more affordable and portable. On the other hand, the introduction of the droplet digital PCR (ddPCR), which integrates conventional PCR with the fluorescence-activated cell sorting aspects, offers a highly automated and robust technology for the detection of scarce targets in samples. These technological advances are expected to increase revenue in this market.
In 2019, the largest share of molecular biology enzymes, reagents, and kits sales came from the pharma and biotech segments. This market was dominated by the pharma and the biotech sectors. The demand for molecular biology enzymes is increasing due to an increase in R&D and ongoing clinical trials at pharma and biotech companies. The shift towards personalized medicine and companion diagnostics has prompted collaborations and mergers in the field of sequencing technology. This has subsequently boosted the demand for sequencing products.
QIAGEN, Inc. entered into a 15 year partnership to expand the use of NGS-based, in vitro diagnostic tools for patient management. QIAGEN has the opportunity to create companion diagnostic tests for tumor evaluations in order to be eligible for immunotherapies using the TruSight Oncology Assays from Illumina. These initiatives will also help to drive segment growth at a profitable pace in the market place for molecular biology enzymes and reagents.
NGS and PCR techniques are widely used in academic research projects, which increases the availability of these products at universities and research centres. Researchers at UNC Medical Center Microbiology and Molecular Microbiology Laboratories investigated the use of NGS to accurately diagnose COVID-19, as reported in March 2020. These entities will also be able to attract funding and investment, which is expected to increase the academic and research segments at a significant CAGR.
North America was the dominant market for molecular biology enzymes and reagents in 2019, accounting for 45.5% of the total revenue. Initiatives such as the Newborn Sequencing in Genomic Medicine and Public Health program of the National Human Genome Research Institute, which screens infants for genetic diseases and boosts the use of NGS technology and its associated kits and reagents, are examples.
Companies based in the U.S. are focusing their efforts on developing technologically advanced products for molecular biological techniques. This will drive the regional market for molecular biotechnology enzymes, kits, and reagents. Crystal Taq, a cost-effective product with higher test accuracy, was launched by Pharmozyme, Inc. in May 2019. This enzyme is free of bacterial and animal DNA contamination, and it reduces background contamination.
The Asia Pacific market for molecular biology enzymes and reagents is expected to grow at a significant rate over the forecast period. The region's growth is influenced by regional players continuing to develop and commercialize point-of-care PCR equipment and other reagents. Fujifilm Wako Pure Chemical Corp., a Japan-based company, began the commercialization in May 2020 of PCR reagents to the automated coronavirus testing device.
Many companies, investors, scientific communities, as well as scientists, have been attracted to molecular biology enzymes, kits, and reagents for a variety of applications such as PCR and sequencing. These companies continue to expand their technology portfolios in order to make these products more accessible, affordable, user-friendly, innovative, as well as more accessible. Agilent Technologies launched the Agilent SureSelect XT HS2DNA Kit in January 2020. This kit was created to address the difficulties researchers face when preparing DNA sequencing libraries. Researchers can now choose the workflow that best suits their needs with this new product. This product development will allow the company to speed up its capture-based enrichment library preparation activities. The following are some of the major players in the market for molecular biology enzymes and reagents.
Thermo Fisher Scientific, Inc.
QIAGEN
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories Inc.
New England Biolabs
Merck KGaA
Promega Corporation
Takara Bio, Inc.
LGC Limited
Up Market Research published a new report titled “Molecular Biology Enzymes, Reagents And Kits Market research report which is segmented by Application (Sequencing, Restriction Digestion, Cloning), By Players/Companies New England Biolabs, QIAGEN, LGC Limited, Merck KGaA, Takara Bio Inc, F Hoffmann-La Roche Ltd, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Promega Corporation, Illumina Inc, Bio-Rad Laboratories Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Molecular Biology Enzymes, Reagents And Kits Market Research Report |
By Application | Sequencing, Restriction Digestion, Cloning |
By Companies | New England Biolabs, QIAGEN, LGC Limited, Merck KGaA, Takara Bio Inc, F Hoffmann-La Roche Ltd, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Promega Corporation, Illumina Inc, Bio-Rad Laboratories Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 206 |
Number of Tables & Figures | 145 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Application (Sequencing, Restriction Digestion, Cloning).
Molecular Biology Enzymes, Reagents And Kits Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Molecular Biology Enzymes, Reagents And Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Molecular Biology Enzymes, Reagents And Kits Market Report:
Some other reports from this category!